HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.

Abstract
Bacterial conjunctivitis appears to resolve more rapidly when treated with appropriate topical antimicrobial agents. In this multicenter, randomized, double-blind study of efficacy and safety, patients with presumed bacterial external eye infections were assigned to topical therapy with 0.3% norfloxacin or 0.3% tobramycin. A total of 120 patients were enrolled. Of the total, 65 had documented bacterial infections and were evaluable; 59 of these patients had bacterial conjunctivitis. All of the patients with documented infections were cured or improved regardless of the drug treatment regimen or in vitro susceptibility testing results. The most common bacteria isolated were Haemophilus influenzae, Streptococcus pneumoniae, alpha-hemolytic streptococci, Staphylococcus aureus, and Staphylococcus sp. No patients had serious adverse reactions attributed to their therapy. Norfloxacin ophthalmic solution seems to be a safe, effective, and appropriate agent for the treatment of bacterial external eye infections.
AuthorsJ A Jacobson, N B Call, E M Kasworm, M S Dirks, R B Turner
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 32 Issue 12 Pg. 1820-4 (Dec 1988) ISSN: 0066-4804 [Print] United States
PMID3072923 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Ophthalmic Solutions
  • Norfloxacin
  • Tobramycin
Topics
  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Blepharitis (drug therapy, microbiology)
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Conjunctiva (microbiology)
  • Conjunctivitis, Bacterial (drug therapy, microbiology)
  • Double-Blind Method
  • Eyelid Diseases (drug therapy)
  • Eyelids (microbiology)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Norfloxacin (therapeutic use)
  • Ophthalmic Solutions
  • Random Allocation
  • Tobramycin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: